Data integrity remains one of the most cited issues in FDA Warning Letters and EMA GMP deficiency reports. This article explains the ALCOA+ principles in plain language, identifies the highest-risk data systems in pharmaceutical operations, and outlines a practical remediation framework. Targeted at quality assurance professionals and laboratory managers.
